How does glutamate affect dopamine in schizophrenia?

The glutamate hypothesis of schizophrenia is centered on a deficiency in activity of glutamate at the glutamate synapse, especially in the prefrontal cortex [48,49]. In many brain areas, dopamine inhibits glutamate release, or glutamate excites neurons that dopamine inhibits [49].

Do antipsychotics lower glutamate?

Neuroimaging studies in schizophrenia have linked elevated glutamate metabolite levels to non-remission following antipsychotic treatment, and also indicate that antipsychotics can reduce glutamate metabolite levels.

What does glutamate do to dopamine?

The interaction between glutamate and dopamine in VTA and NAS is rather complex, but in simplified terms, glutamatergic input to the VTA increases the activity of dopaminergic cells and enhances dopamine release in the NAS.

Is dopamine inhibitory or excitatory in schizophrenia?

Dopamine is an inhibitory neurotransmitter involved in the pathology of schizophrenia. The revised dopamine hypothesis states that dopamine abnormalities in the mesolimbic and prefrontal brain regions exist in schizophrenia.

Is glutamate linked to schizophrenia?

Glutamate and dopamine systems play distinct roles in terms of neuronal signalling, yet both have been proposed to contribute significantly to the pathophysiology of schizophrenia.

Is glutamate increased or decreased in schizophrenia?

Group-by-age associations revealed that in patients with schizophrenia, glutamate and glutamine concentrations decreased at a faster rate with age as compared with healthy controls.

Do atypical antipsychotics increase glutamate?

Atypical antipsychotics may also indirectly modulate glutamate release by modifying glutamatergic receptor activity or density (43–45).

What drugs act on glutamate?

Table 1

Target	Drug	Major mechanism of action
Group III mGluR8	RS-PPG	mGluR8 agonist
Other	Riluzole	Reduces extra-synaptic glutamate by inhibiting presynaptic release, enhances astroglial uptake
	Lamotrigine	Inhibits voltage-dependent channels to reduce glutamate release
	Acamprosate	NMDA and mGluR5 antagonist

What does glutamate do for schizophrenia?

Glutamate is the major excitatory neurotransmitter of the central nervous system. The finding that antagonists of a specific glutamate receptor, the N‐methyl‐D‐aspartate (NMDA) receptor, induce psychotic symptoms has led to a wealth of research implicating the glutamate system in the pathophysiology of schizophrenia.

Is glutamate high or low in schizophrenia?

A study using a heat pain stress found a reduced anterior cingulate cortex glutamate response in individuals with schizophrenia compared to healthy controls168, although interpretation is complicated by the fact that baseline glutamate levels were higher in patients.

Does glutamate control dopamine?

All of the established glutamate receptor subtypes identified to date have been implicated in the regulation of dopamine release. It appears that glutamate can exert both facilitatory and inhibitory control over dopamine release and that this may be both phasic and tonic in nature.

Can glycine and D-serine modulate the glutamate system in schizophrenia?

Early studies investigating modulation of the glutamate system using glycine, D-serine and sarcosine in patients with schizophrenia have demonstrated significant effects, particularly on negative symptoms, conventionally thought to be refractory to antipsychotic drug treatment.

Are glutamatergic drugs useful in the treatment of early-stage schizophrenia?

It has been hypothesized that glutamatergic drugs may be of benefit to the 20–30% of individuals with schizophrenia who fail to show any response to dopaminergic agents, and may be particularly useful in the early stages of the illness, where they may be disease-modifying.

Do NMDA receptor antagonists increase glutamate release?

Hypothesized mechanism whereby NMDA receptor antagonists lead to increased cortical glutamate release: inhibition of NMDA receptors expressed on GABAergic interneurons (A) leads disinhibition of glutamatergic projection neurons (B).

What is the difference between dopamine D2 antagonists and glutamate antagonists?

Drugs targeting the glutamate system also have a completely different side-effect profile to dopamine D2 antagonists, with no propensity to extrapyramidal side effects, prolactinaemia or weight gain.